Bones and muscular dystrophies: what do we know?

被引:7
作者
Wood, Claire L. [1 ,2 ,3 ]
Straub, Volker [1 ,2 ]
机构
[1] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, MRC Ctr Neuromuscular Dis, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England
[3] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland
关键词
muscle-bone interaction; muscular dystrophies; osteoporosis; MINERAL DENSITY; BISPHOSPHONATE THERAPY; VERTEBRAL FRACTURES; RISK-FACTORS; LIMB-GIRDLE; DUCHENNE; OSTEOPOROSIS; DIAGNOSIS; MECHANISMS; CHILDREN;
D O I
10.1097/WCO.0000000000000603
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Muscle and bone are intrinsically linked, and therefore, it is not surprising that many muscular dystrophies are associated with impaired bone health and increased risk of osteoporosis. Osteoporotic fracture is an important and preventable cause of morbidity and mortality. This article will firstly review the general causes of impaired bone health in muscular dystrophies and then focus on the evidence available for the diagnosis and treatment of osteoporosis in specific conditions. Recent findings With the exception of DMD, there is a paucity of data regarding bone health in muscular dystrophies. However, it appears that in common with all types of muscular dystrophies that cause a significant level of muscle weakness and disability there is an increased risk of falls, fractures and decreased vitamin D levels. A better understanding of the extent of the impaired bone health and underlying causes could help to identify potential new therapeutic agents and aid clinical care. Summary It would be prudent for clinicians to assess fracture risk in their muscular dystrophy patients and if appropriate, arrange surveillance and recommend vitamin D supplementation. Additionally, fracture should be considered in any patient presenting with new-onset bone pain.
引用
收藏
页码:583 / 591
页数:9
相关论文
共 71 条
[1]  
Al-Harbi Talal M, 2008, J Clin Neuromuscul Dis, V9, P397, DOI 10.1097/CND.0b013e318176eb55
[2]  
[Anonymous], 2005, NUTR B, V30, P237
[3]   Acquisition of optimal bane mass in childhood and adolescence [J].
Bachrach, LK .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (01) :22-28
[4]   Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy [J].
Bell, Jennifer M. ;
Shields, Michael D. ;
Watters, Janet ;
Hamilton, Alistair ;
Beringer, Timothy ;
Elliott, Mark ;
Quinlivan, Rosaline ;
Tirupathi, Sandya ;
Blackwood, Bronagh .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01)
[5]   Bone mineral density and bone metabolism in Duchenne muscular dystrophy [J].
Bianchi, ML ;
Mazzanti, A ;
Galbiati, E ;
Saraifoger, S ;
Dubini, A ;
Cornelio, F ;
Morandi, L .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (09) :761-767
[6]   Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management [J].
Birnkrant, David J. ;
Bushby, Katharine ;
Bann, Carla M. ;
Alman, Benjamin A. ;
Apkon, Susan D. ;
Blackwell, Angela ;
Case, Laura E. ;
Cripe, Linda ;
Hadjiyannakis, Stasia ;
Olson, Aaron K. ;
Sheehan, Daniel W. ;
Bolen, Julie ;
Weber, David R. ;
Ward, Leanne M. .
LANCET NEUROLOGY, 2018, 17 (04) :347-361
[7]  
Birnkrant DJ, 2018, LANCET NEUROL, V17, P251, DOI 10.1016/S1474-4422(18)30024-3
[8]   Vertebral morphometry studies using dual-energy x-ray absorptiometry [J].
Blake, GM ;
Rea, JA ;
Fogelman, I .
SEMINARS IN NUCLEAR MEDICINE, 1997, 27 (03) :276-290
[9]   Vertebral fractures in boys with Duchenne muscular dystrophy [J].
Bothwell, JE ;
Gordon, KE ;
Dooley, JM ;
MacSween, J ;
Cummings, EA ;
Salisbury, S .
CLINICAL PEDIATRICS, 2003, 42 (04) :353-356
[10]   Renal function in children and adolescents with Duchenne muscular dystrophy [J].
Braat, Bike ;
Hoste, Liesbeth ;
De Waele, Liesbeth ;
Gheysens, Olivier ;
Vermeersch, Pieter ;
Goffin, Karolien ;
Pottel, Hans ;
Goemans, Nathalie ;
Levtehenko, Elena .
NEUROMUSCULAR DISORDERS, 2015, 25 (05) :381-387